stockrow
Friday 6 November 2026
Export MANE’s income statement to Excel — free account
Veradermics Incorporated
MANE Healthcare Biotechnology
138.19
9.59
+7.46%
Follow MANE
Alert me
| Jun '26 | Mar '26 | Dec '25 | Jun '25 | Older periods | |
|---|---|---|---|---|---|
| 0.00% | — | — | — |
+2 more TTM periods Free account |
|
| (20.86%) | 0.00% | — | — | ||
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | |
Return on Tangible Assets |
(10.59%) | 0.00% | 0.00% | — | |
Free Cash Flow per Share |
(3.04) | (5.36) | 0.00 | 0.00 | |
Free Cash Flow |
(122.97) | (121.73) | (124.29) | — | |
Capital Expenditures |
(0.06) | — | (0.04) | — | |
| Other line items | |||||
Cash ROIC |
(7.53%) | (15.58%) | (596.19%) | 0.00% | |
Average Days of Payables |
0.00 | 0.00 | 0.00 | — | |
Tax Rate |
0.00 | — | — | — | |
Research and Development Expense of Revenue |
0.00% | — | — | — | |
Selling, General and Administrative Expense of Revenue |
0.00% | — | — | — | |
Share Based Compensation of Revenue |
0.00% | — | — | — | |
Operating CF/Net income |
1.43 | 0.00 | 0.00 | — | |
Depreciation/Fixed assets |
0.00 | 0.00 | 0.00 | — | |
Capex/Depreciation |
0.00 | — | 0.00 | — | |
Revenue per Share |
0.00 | 0.00 | — | 0.00 | |
Operating CF per Share |
(3.04) | (5.36) | 0.00 | 0.00 | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.00 | — | 0.00 | — |
Columns are period end dates · fundamentals updated 25 Oct 2026